Vinorelbine and paclitaxel for locoregional advanced or metastatic non-small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 4, 2002, Pages 383-387

  Pérez, Juan E ^a   Machiavelli, Mario R ^a   Romero, Alberto O ^a   Acuña, Luis A Romero ^a   Domínguez, María E ^a   Fasce, Hebe ^a   Acosta, Luis Flores ^a   Marrone, Nora ^a   Acuña, Juan M Romero ^a   Langhi, Mario J ^a   Amato, Sonia ^a   Bologna, Fabrina ^a   Ortiz, Eduardo H ^a   Leone, Bernardo A ^a   Lacava, Juan A ^a   Vallejo, Carlos T ^a  

^a Rivadavia 360   (Argentina)

Author keywords

Lung cancer; Paclitaxel; Vinorelbine

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; NAVELBINE; PACLITAXEL; RANITIDINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; FEMALE; HUMAN; LEUKOPENIA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MYALGIA; NEUTROPENIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL TIME; TOXICITY; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0036337931     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200208000-00013     Document Type: Article

References (32)

1. Surgery in non-small cell lung cancer
2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
3. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
4. Vinorelbine (Navelbine) in the treatment of non-small cell lung cancer: Studies with single-agent therapy and in combination with cisplatin
5. Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer
6. Preclinical activity of Navelbine and Taxol drug combinations
7. Synergy of Navelbine, Taxol combination treatment in two human breast cancer cell lines
8. In vitro synergy of paclitaxel (Taxol) and vinorelbine (Navelbine) against human melanoma cell lines
9. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer
10. Pilot study of vinorelbine (Navelbine) and paclitaxel in patients with refractory non-small-cell lung cancer
11. Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study
12. Phase I, study of vinorelbine (Navelbine) and paclitaxel (Taxol) by simultaneously 3-hour infusion with G-CSF support, for untreated metastatic breast cancer [Abstract 107]
13. Simultaneous Infusion of vinorelbine (VNB) and paclitaxel (P) as first-line chemotherapy (CT) in advanced breast cancer (ABC) patients (pts)
14. Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
15. Reporting results of cancer treatment
16. Appendix-WHO toxicity guidelines
17. Effective prevention of chemotherapy-induced phlebitis by low-dose heparin: A prospective randomized trial
18. Nonparametric estimation from incomplete observations
19. The importance of dose intensity in chemotherapy of metastatic breast cancer
20. Exploratory data analysis and the use of the hazard function for interpreting survival data: An investigator's prime
21. Chemotherapy for advanced non-small-cell lung cancer: Modest progress, many choices
22. Multidrug resistance
23. Altered cell surface membrane glycoproteins in vinca-alkaloid-resistance human leukemic lymphoblasts
24. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells
25. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-to-170 kDa protein detected by photoaffinity labeling
26. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells
27. In situ selection of a human rhabdomyo-sarcoma resistant to vincristine with altered alpha-tubulins
28. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin
29. A mechanism of cellular resistance to drugs that interfere with microtubule assembly
30. Resistance to the antimitotic agents as genetic probes of microtubule structure and function
31. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations